Òscar M. Tirado

3.1k total citations
57 papers, 1.8k citations indexed

About

Òscar M. Tirado is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Òscar M. Tirado has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 22 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Òscar M. Tirado's work include Sarcoma Diagnosis and Treatment (20 papers), Cell death mechanisms and regulation (8 papers) and Caveolin-1 and cellular processes (7 papers). Òscar M. Tirado is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Cell death mechanisms and regulation (8 papers) and Caveolin-1 and cellular processes (7 papers). Òscar M. Tirado collaborates with scholars based in Spain, United States and United Kingdom. Òscar M. Tirado's co-authors include Silvia Mateo‐Lozano, Vicente Notario, Laura Lagares‐Tena, Joaquín Villar, Francina Munell, Carlos A. Suárez‐Quian, Jaume Reventós, David M. Selva, Miguel Sáinz‐Jaspeado and Xavier García del Muro and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Òscar M. Tirado

56 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Òscar M. Tirado Spain 28 952 533 435 297 262 57 1.8k
Yuzo Furuya Japan 22 923 1.0× 731 1.4× 510 1.2× 359 1.2× 102 0.4× 83 1.9k
Briana J. Williams United States 26 1.1k 1.2× 376 0.7× 264 0.6× 265 0.9× 166 0.6× 48 2.0k
Saila Kauppila Finland 25 914 1.0× 357 0.7× 797 1.8× 384 1.3× 180 0.7× 42 2.3k
Jacek Pinski United States 31 1.1k 1.2× 1.1k 2.1× 727 1.7× 415 1.4× 258 1.0× 114 2.9k
Enke Baldini Italy 27 754 0.8× 179 0.3× 681 1.6× 406 1.4× 353 1.3× 90 2.3k
Bianca Maria Veneziani Italy 22 1.0k 1.1× 689 1.3× 821 1.9× 338 1.1× 105 0.4× 51 2.0k
Ricardo Sánchez‐Prieto Spain 26 1.3k 1.4× 272 0.5× 696 1.6× 374 1.3× 144 0.5× 74 2.1k
Paola Concolino Italy 19 757 0.8× 206 0.4× 357 0.8× 119 0.4× 235 0.9× 62 1.4k
Jan Bouchal Czechia 27 1.5k 1.6× 449 0.8× 939 2.2× 613 2.1× 211 0.8× 86 2.6k
Caiping Ren China 31 1.7k 1.8× 296 0.6× 543 1.2× 896 3.0× 163 0.6× 116 2.6k

Countries citing papers authored by Òscar M. Tirado

Since Specialization
Citations

This map shows the geographic impact of Òscar M. Tirado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Òscar M. Tirado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Òscar M. Tirado more than expected).

Fields of papers citing papers by Òscar M. Tirado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Òscar M. Tirado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Òscar M. Tirado. The network helps show where Òscar M. Tirado may publish in the future.

Co-authorship network of co-authors of Òscar M. Tirado

This figure shows the co-authorship network connecting the top 25 collaborators of Òscar M. Tirado. A scholar is included among the top collaborators of Òscar M. Tirado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Òscar M. Tirado. Òscar M. Tirado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mateo‐Lozano, Silvia, et al.. (2025). Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis. Molecular Oncology. 19(4). 1002–1028.
2.
Pascual‐Pasto, Guillem, Helena Castillo‐Ecija, Mònica Vilà-Ubach, et al.. (2023). Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma. Biochemical Pharmacology. 208. 115408–115408. 7 indexed citations
3.
Dassie, Justin P., et al.. (2023). Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors. Molecular Therapy — Nucleic Acids. 32. 758–772. 8 indexed citations
4.
García-Domínguez, Daniel J., Nabil Hajji, Roser López‐Alemany, et al.. (2022). Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1. Oncogene. 41(18). 2638–2650. 17 indexed citations
5.
Manara, Maria Cristina, Sérgio Valente, Alberto Bavelloni, et al.. (2022). Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response. Frontiers in Endocrinology. 13. 876602–876602. 9 indexed citations
6.
Díaz‐Riascos, Zamira V., Xavier Délen, Patrick Georges, et al.. (2021). Harnessing subcellular-resolved organ distribution of cationic copolymer-functionalized fluorescent nanodiamonds for optimal delivery of active siRNA to a xenografted tumor in mice. Nanoscale. 13(20). 9280–9292. 15 indexed citations
7.
Pascual‐Pasto, Guillem, Helena Castillo‐Ecija, Nora Unceta, et al.. (2021). SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas. Journal of Controlled Release. 342. 81–92. 30 indexed citations
8.
Sánchez-Molina, Sara, Enrique Blanco, Soledad Gómez‐González, et al.. (2020). RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis. Science Advances. 6(43). 23 indexed citations
9.
Herrero‐Martín, David, Santiago Rello‐Varona, Enrique de Álava, et al.. (2020). LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity. Cancer Letters. 474. 1–14. 16 indexed citations
10.
Oliveira-Mateos, Cristina, Marta Soler, David Piñeyro, et al.. (2019). The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition. Nature Communications. 10(1). 3979–3979. 45 indexed citations
11.
Ban, Jozef, Dave N.T. Aryee, Wietske van der Ent, et al.. (2014). Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma. Cancer Research. 74(22). 6578–6588. 57 indexed citations
12.
Sáinz‐Jaspeado, Miguel, Laura Lagares‐Tena, Silvia Mateo‐Lozano, et al.. (2013). Abstract 3827: Caveolin-1 acts as a tumor suppressor promoting muscular differentiation in alveolar rhabdomyosarcomas.. Cancer Research. 73(8_Supplement). 3827–3827. 1 indexed citations
13.
Lagares‐Tena, Laura, et al.. (2012). Targeted Therapies in Sarcomas: Challenging the Challenge. Sarcoma. 2012. 1–13. 23 indexed citations
14.
Ramírez‐Peinado, Silvia, Laura Lagares‐Tena, Nadia El Mjiyad, et al.. (2011). 2-Deoxyglucose Induces Noxa-Dependent Apoptosis in Alveolar Rhabdomyosarcoma. Cancer Research. 71(21). 6796–6806. 78 indexed citations
15.
Sáinz‐Jaspeado, Miguel, Laura Lagares‐Tena, Fariba Navid, et al.. (2010). Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize. Molecular Cancer Research. 8(11). 1489–1500. 46 indexed citations
16.
Tirado, Òscar M., et al.. (2009). Caveolin‐1 promotes resistance to chemotherapy‐induced apoptosis in Ewing's sarcoma cells by modulating PKCα phosphorylation. International Journal of Cancer. 126(2). 426–436. 37 indexed citations
17.
18.
Bettayeb, Karima, Òscar M. Tirado, Séverine Marionneau‐Lambot, et al.. (2007). Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases. Cancer Research. 67(17). 8325–8334. 95 indexed citations
19.
Tirado, Òscar M., Silvia Mateo‐Lozano, Joaquín Villar, et al.. (2006). Caveolin-1 ( CAV1 ) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells. Cancer Research. 66(20). 9937–9947. 120 indexed citations
20.
Mateo‐Lozano, Silvia, Òscar M. Tirado, & Vicente Notario. (2003). Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation. Oncogene. 22(58). 9282–9287. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuzo Furuya Breakdown of academic impact, for papers by Briana J. Williams Breakdown of academic impact, for papers by Saila Kauppila Breakdown of academic impact, for papers by Jacek Pinski Breakdown of academic impact, for papers by Enke Baldini Breakdown of academic impact, for papers by Bianca Maria Veneziani Breakdown of academic impact, for papers by Ricardo Sánchez‐Prieto Breakdown of academic impact, for papers by Paola Concolino Breakdown of academic impact, for papers by Jan Bouchal Breakdown of academic impact, for papers by Caiping Ren
Rankless by CCL
2026